[go: up one dir, main page]

PE20020232A1 - Bacterias acido lacticas como lactobacillus, bifidobacterium y streptococcus aisladas por su potencial probiotico para aplicaciones de alimento de mascotas - Google Patents

Bacterias acido lacticas como lactobacillus, bifidobacterium y streptococcus aisladas por su potencial probiotico para aplicaciones de alimento de mascotas

Info

Publication number
PE20020232A1
PE20020232A1 PE2001000477A PE2001000477A PE20020232A1 PE 20020232 A1 PE20020232 A1 PE 20020232A1 PE 2001000477 A PE2001000477 A PE 2001000477A PE 2001000477 A PE2001000477 A PE 2001000477A PE 20020232 A1 PE20020232 A1 PE 20020232A1
Authority
PE
Peru
Prior art keywords
bifidobacterium
lactic acid
acid bacteria
lactobacillus
pets
Prior art date
Application number
PE2001000477A
Other languages
English (en)
Inventor
Roberto Reniero
Florence Rochat
Eduardo Schiffrin
Pablo Perez
Ralf Zink
Christoph Cavadini
Der Wei Thierry Von
Jalil Benyacoub
Virginie Rousseau
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestle Sa filed Critical Nestle Sa
Publication of PE20020232A1 publication Critical patent/PE20020232A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A23K50/42—Dry feed
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A23K50/48—Moist feed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C12R2001/23—Lactobacillus acidophilus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/46—Streptococcus ; Enterococcus; Lactococcus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S426/00—Food or edible material: processes, compositions, and products
    • Y10S426/805—Pet food for dog, cat, bird, or fish

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Husbandry (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Birds (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Physiology (AREA)
  • Dermatology (AREA)
  • Fodder In General (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

SE REFIERE A CEPAS AISLADAS DE BACTERIAS DE ACIDO LACTICO COMO LACTOBACILLUS REUTERI; L. ACIDOPHILUS, L. ANIMALS, L. RUMINIS, L. JOHNSONII, L. CASEI, L. PARACASEI, L. RHAMNOSUS, L. FERMENTUM, BIFIDOBACTERIUM sp, ENTEROCCUS FAECIUM QUE TIENEN AFINIDAD PROBIOTICA; SELECCIONADAS POR SU CAPACIDAD PARA SOBREVIVIR Y COLONIZAR EL TRACTO GASTROINTESTINAL DE MASCOTAS, QUE TIENE CAPACIDAD DE CRECER PRODUCIENDO AL MENOS 1.OE +06 cfu/ml EN LA PRESENCIA DE HASTA 2% DE SALES BILIARES; DESPUES DE 2 HORAS A UN INTERVALO DE pH DE 3,4 A 4,2. LOS PROBIOTICOS PUEDEN SER UTILES PARA EL TRATAMIENTO Y PROFILAXIS DE TRASTORNOS ASOCIADOS CON LA COLONIZACION DEL TRACTO INTESTINAL EN MASCOTAS POR MICROORGANISMOS PATOGENOS, REGULAR EL SISTEMA DE PELAJE DE MASCOTAS, MEJORA O REDUCCION DE LOS EFECTOS DE ENVEJECIMEINTO EN MASCOTAS
PE2001000477A 2000-05-25 2001-05-24 Bacterias acido lacticas como lactobacillus, bifidobacterium y streptococcus aisladas por su potencial probiotico para aplicaciones de alimento de mascotas PE20020232A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00201867 2000-05-25
EP01201503 2001-04-25

Publications (1)

Publication Number Publication Date
PE20020232A1 true PE20020232A1 (es) 2002-04-16

Family

ID=26072297

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2001000477A PE20020232A1 (es) 2000-05-25 2001-05-24 Bacterias acido lacticas como lactobacillus, bifidobacterium y streptococcus aisladas por su potencial probiotico para aplicaciones de alimento de mascotas

Country Status (24)

Country Link
US (5) US7189390B2 (es)
EP (2) EP1541673B1 (es)
JP (2) JP4343477B2 (es)
KR (1) KR100796963B1 (es)
CN (1) CN100396769C (es)
AR (1) AR029100A1 (es)
AT (1) ATE325864T1 (es)
AU (2) AU2001278432B2 (es)
BR (1) BR0111275B1 (es)
CA (1) CA2409286C (es)
DE (2) DE60127731T2 (es)
EA (1) EA006428B1 (es)
ES (2) ES2262667T3 (es)
HU (1) HU230800B1 (es)
IL (2) IL152695A0 (es)
MX (1) MXPA02011595A (es)
MY (1) MY138070A (es)
NO (1) NO330276B1 (es)
NZ (1) NZ523010A (es)
PE (1) PE20020232A1 (es)
PL (1) PL207930B1 (es)
UY (1) UY26734A1 (es)
WO (1) WO2001090311A1 (es)
ZA (1) ZA200210302B (es)

Families Citing this family (129)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8563522B2 (en) 1997-07-08 2013-10-22 The Iams Company Method of maintaining and/or attenuating a decline in quality of life
US20060116330A1 (en) * 1997-07-08 2006-06-01 The Iams Company Methods of mimicking the metabolic effects of caloric restriction by administration of mannoheptulose
US20020035071A1 (en) * 1997-07-08 2002-03-21 Josef Pitha Mimicking the metabolic effects of caloric restriction by administration of glucose antimetabolites
US7608291B2 (en) * 2000-03-10 2009-10-27 Mars, Inc. Treatment of infection in animals
ES2262667T3 (es) * 2000-05-25 2006-12-01 Societe Des Produits Nestle S.A. Probioticos nuevos para aplicaciones en alimento para animales de compañia.
US20040028665A1 (en) 2002-01-08 2004-02-12 Garner Bryan E. Compositions and methods for inhibiting pathogenic growth
GB0212975D0 (en) 2002-06-06 2002-07-17 Mars Uk Ltd Mammalian animal composition
US8168170B2 (en) * 2002-10-03 2012-05-01 The Procter And Gamble Company Compositions having an inner core and at least three surrounding layers
WO2004062388A1 (en) 2003-01-06 2004-07-29 Nutrition Physiology Corporation Compositions and methods for reducing the pathogen content of meat and meat products
US20040197304A1 (en) * 2003-04-01 2004-10-07 The Procter & Gamble Company And Alimentary Health, Ltd. Methods of determining efficacy of treatments of inflammatory diseases of the bowel
KR101183565B1 (ko) 2003-06-20 2012-09-17 뉴트리니아 리미티드 생활성 화합물의 보호 방법 및 생활성 성분을 포함하는 조성물
US20050100559A1 (en) * 2003-11-07 2005-05-12 The Procter & Gamble Company Stabilized compositions comprising a probiotic
US20050118234A1 (en) * 2003-12-01 2005-06-02 The Iams Company Methods and kits related to administration of a fructooligosaccharide
US20050119222A1 (en) * 2003-12-01 2005-06-02 The Iams Company Compositions comprising fermentable fiber which are adapted for use by a companion animal and kits and methods of their use
US20050238631A1 (en) * 2003-12-04 2005-10-27 Steve Burwell Methods and compositions for preventing biofilm formation, reducing existing biofilms, and for reducing populations of bacteria
US8877178B2 (en) * 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US20050152884A1 (en) 2003-12-19 2005-07-14 The Procter & Gamble Company Canine probiotic Bifidobacteria globosum
US20050158294A1 (en) * 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US8894991B2 (en) 2003-12-19 2014-11-25 The Iams Company Canine probiotic Lactobacilli
US7785635B1 (en) * 2003-12-19 2010-08-31 The Procter & Gamble Company Methods of use of probiotic lactobacilli for companion animals
JP2005224108A (ja) * 2004-02-10 2005-08-25 Yamahisa:Kk ペット用スナックフード
GB0406654D0 (en) * 2004-03-24 2004-04-28 Mars Inc Foodstuff
WO2005115473A2 (en) 2004-05-24 2005-12-08 Nutrinia Ltd. Nutritional food and feed, composition, processing and method of use
KR100595528B1 (ko) * 2004-08-21 2006-07-03 전덕영 내산성, 내산소성 및 내염성이 우수한 비피도박테리움 아니말리스 ｄｙ－６４ 및 이를 함유한 식품
EP1634948A1 (en) 2004-09-10 2006-03-15 Basf Aktiengesellschaft Means and methods for preventing and/or treating caries
DE602004013441T2 (de) * 2004-09-21 2009-06-04 Nestec S.A. Verbesserung der Lebensdauer alter Katzen
US20100233312A9 (en) * 2005-04-11 2010-09-16 The Procter & Gamble Company Compositions comprising probiotic and sweetener components
US20060228448A1 (en) * 2005-04-11 2006-10-12 The Iams Company Pet food compositions comprising two components
DK1880001T3 (da) 2005-05-31 2011-09-12 Iams Company Feline probiotiske lactobacilli
EP1885383B1 (en) 2005-05-31 2016-09-21 IAMS Europe B.V. Feline probiotic bifidobacteria
AU2011202947B2 (en) * 2005-05-31 2011-11-03 Alimentary Health Ltd Feline probiotic lactobacilli
ITMI20051137A1 (it) * 2005-06-17 2006-12-18 Ista S P A Metodo per prevenire l'inattivazione da parte di batteriofagi specifici di miscele di ceppi probiotici utilizzati negli allevamenti animali
KR100720025B1 (ko) * 2005-09-27 2007-05-21 (주)바이오토피아 프로바이오틱 유산균 및 이를 포함하는 조성물
US20070280964A1 (en) * 2005-10-06 2007-12-06 Ruth Knorr Compositions and methods useful for modulating immunity, enhancing vaccine efficacy, decreasing morbidity associated with chronic FHV-1 infections, and preventing or treating conjunctivitis
JP5155170B2 (ja) * 2005-10-06 2013-02-27 ネステク ソシエテ アノニム 免疫を改善するためのプロバイオティックエンテロコッカス
JP4897426B2 (ja) * 2005-10-18 2012-03-14 花王株式会社 ペットフード
EP1951065A1 (en) * 2005-10-19 2008-08-06 Hill's Pet Nutrition Inc. Methods and compositions for improving gastrointestinal health
ES2379824T3 (es) * 2005-12-29 2012-05-04 Hill's Pet Nutrition, Inc. Método para modificar la flora intestinal en animales
MX2008011958A (es) * 2006-03-29 2008-10-01 Nestec Sa Suplementos dieteticos que contienen probioticos.
CN101454439B (zh) * 2006-05-31 2011-01-26 明治乳业株式会社 免疫调节活性高的乳酸菌的培养法
FR2903574B1 (fr) * 2006-07-13 2008-09-05 Gervais Danone Sa Granules de cysteine et leurs utilisations a titre d'activateurs de croissance de bifidobacterium animalis lactis.
KR100720024B1 (ko) * 2006-12-20 2007-05-18 (주)바이오토피아 프로바이오틱 비피도박테리움 보움 ｒ5 균주 및 이를포함하는 조성물
ES2551719T3 (es) 2007-02-01 2015-11-23 Iams Europe B.V. Procedimiento para disminuir la inflamación y el estrés en un mamífero usando antimetabolitos de glucosa, aguacate o extractos de aguacate
US7910127B2 (en) * 2007-03-02 2011-03-22 Biogaia Ab Use of lactic acid bacteria for improving food lysine absorption of pet animals
EP2190299B1 (en) * 2007-08-29 2021-01-06 Mars, Incorporated Method of providing a cat food product in single-serve portions
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US9232813B2 (en) * 2008-07-07 2016-01-12 The Iams Company Probiotic supplement, process for making, and packaging
WO2010077356A1 (en) 2009-01-02 2010-07-08 Nestec S.A. Food compositions having a realistic meat-like appearance, feel and texture
US9474773B2 (en) 2009-02-18 2016-10-25 University Of Florida Research Foundation, Inc. Lactobacillus supplement for alleviating type 1 diabetes
US20100233347A1 (en) 2009-03-13 2010-09-16 Uhrhan Richard B Food compositions having a realistic meat-like appearance, feel, and texture
DE102009032712A1 (de) * 2009-05-22 2010-11-25 Growth Finance Plus Ag Tierfutter
US20110027417A1 (en) † 2009-07-31 2011-02-03 Patrick Joseph Corrigan Process for Dusting Animal Food
US9210945B2 (en) * 2009-07-31 2015-12-15 The Iams Company Animal food having low water activity
US8691303B2 (en) * 2009-07-31 2014-04-08 The Iams Company Dusted animal food
US9173423B2 (en) * 2009-07-31 2015-11-03 The Iams Company Animal food kibble with electrostatically adhered dusting
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
US20110027420A1 (en) * 2009-07-31 2011-02-03 Haile Mehansho Moisture migration reduction layer for a food product
FI122247B (fi) 2009-08-12 2011-10-31 Vetcare Oy Probioottinen valmiste koiran maha- ja suolistokanavassa ilmenevien häiriöiden ennaltaehkäisemiseksi tai hoitamiseksi
AU2010317423C1 (en) 2009-11-11 2015-01-22 Alimentary Health Limited A bifidobacterium strain
CN102651973A (zh) 2009-12-18 2012-08-29 希尔氏宠物营养品公司 包含益生菌的宠物食物组合物及其制造和使用方法
AU2011258854B2 (en) 2010-05-26 2016-02-11 Nestec S.A. Methods for increasing the production or activity of catalase
WO2012039745A1 (en) * 2010-09-23 2012-03-29 Nestec S.A. Methods and compositions for preventing or treating osteoarthritis
WO2012060884A1 (en) * 2010-11-04 2012-05-10 Nestec S.A. Methods and compositions for preventing and treating osteoarthritis
EP2449890A1 (en) * 2010-11-05 2012-05-09 Nestec S.A. Powdered cereal compositions comprising non-replicating probiotic microorganisms
ES2565407T3 (es) 2010-11-05 2016-04-04 Nestec S.A. Procedimiento para la preparación de un producto alimenticio para animales de compañía, el cual contiene microorganismos probióticos
EP2452576A1 (en) * 2010-11-11 2012-05-16 Nestec S.A. Extruded non-replicating probiotic micro-organisms and their health benefits
EP2654744A4 (en) * 2010-12-21 2014-07-02 Nestec Sa METHODS AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF ARTHROSIS
BR112013018839A2 (pt) 2011-01-25 2016-09-27 Nestec Sa métodos e composições para o tratamento, a redução ou a prevenção de deterioração do sistema visual dos animais
AU2012231351B2 (en) 2011-03-18 2016-03-10 Société des Produits Nestlé S.A. Compositions and methods useful for ameliorating age related maladies
CA2832234A1 (en) 2011-04-15 2012-10-18 Nestec S.A. Methods for regulating sirtuin gene expression
CN102250799B (zh) * 2011-06-22 2013-09-11 南京农业大学 草酸降解菌njode1及其应用
US20130045185A1 (en) * 2011-08-18 2013-02-21 Dupont Nutrition Biosciences Aps Strains and methods useful for mycotoxins
US9113653B2 (en) 2011-08-19 2015-08-25 Steven J Maranz Methods of administering probiotic organisms that synthesize carotenoid compounds in situ to enhance human health and nutrition
CN102399733B (zh) * 2011-12-14 2014-07-09 北京大北农科技集团股份有限公司 约氏乳杆菌及其菌剂、应用和预混料
CN102578415B (zh) * 2012-02-23 2016-01-20 北京大北农科技集团股份有限公司 约氏乳杆菌在制备提高禽类产蛋性能和蛋品质饲料中的应用
US9585925B1 (en) * 2012-05-04 2017-03-07 Vetnique Labs LLC Pet food supplement
JP6452607B2 (ja) * 2012-09-25 2019-01-16 アキロン セイエレ エセ．エレ． プロバイオティクス組成物及びプレバイオティクス組成物
US10413577B2 (en) * 2013-02-22 2019-09-17 The Regents Of The University Of California Compositions and methods for promoting growth of beneficial microbes to treat or prevent disease or prolong life
CN104286408B (zh) * 2014-06-13 2017-10-24 杨雄 一种嗜酸乳杆菌xd13r制备的生物制剂在减少宠物体内抗药性细菌比例的应用方法
US20160143324A1 (en) 2014-11-25 2016-05-26 Nestec Sa Methods and compositions for preserving lean body mass and promoting fat loss during weight loss
RU2701347C2 (ru) 2014-11-25 2019-09-25 Сосьете Де Продюи Нестле С.А. Способ и композиция для стимулирования безжировой массы тела и минимизации накопления жира в организме и управления массой
WO2016130498A1 (en) * 2015-02-10 2016-08-18 Massachusetts Institute Of Technology Isolated mucins and different microoorganisms, and methods of use
MX2017010321A (es) 2015-02-13 2017-12-07 Mars Inc Sistema de alimentacion para mascotas.
EP3258792A1 (en) 2015-02-16 2017-12-27 Mars, Incorporated Interlocking kibble
AU2016255437B2 (en) 2015-04-28 2020-10-08 Mars, Incorporated Process of preparing a sterilized wet pet food product
GB201520497D0 (en) * 2015-11-20 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
RS57471B1 (sr) 2015-12-17 2018-09-28 Institut Za Molekularnu Genetiku I Geneticko Inzenjerstvo Univerzitet U Beogradu Nova probiotička starter kultura za humanu i animalnu primenu
WO2017109623A1 (en) * 2015-12-22 2017-06-29 Nestec Sa Immune health for companion animals
BR112018013052A2 (pt) 2015-12-24 2018-12-04 Dairy A Day Inc composições e métodos de uso de novas cepas de lactobacillus fermentum
SG11201808154XA (en) 2016-03-24 2018-10-30 Nutrinia Ltd Use of insulin for promoting gastric emptying
CA3035898A1 (en) 2016-09-08 2018-03-15 Morehouse School Of Medicine Cleaning composition, comprising a coated granular absorbent
EP3596223B1 (en) 2017-03-15 2023-06-07 Société des Produits Nestlé S.A. Branched alpha glucans
US11357803B2 (en) 2017-09-22 2022-06-14 Iowa State University Research Foundation, Inc. Probiotic compositions for production of dopamine
CN107821753A (zh) * 2017-11-20 2018-03-23 江苏雅博动物健康科技有限责任公司 一种宠物用益生菌颗粒制剂及其制备方法
WO2019113217A1 (en) * 2017-12-05 2019-06-13 Texas Tech University System Reduction of pathogens and other bacteria in food and feed products utilizing a multiple inhibition system with lactic acid bacteria
US10758577B2 (en) * 2017-12-14 2020-09-01 Pure Cultures 2020, Inc. Probiotics and fermentation metabolites for the prevention and treatment of disease conditions in animals
FI128916B (en) 2018-02-05 2021-03-15 Vetcare Oy Health-promoting composition and method for its preparation
KR102079794B1 (ko) * 2018-09-18 2020-02-20 전북대학교산학협력단 신규한 엔테로코커스 패시움 균주 및 이의 용도
EP3849334A1 (en) 2018-10-18 2021-07-21 Hill's Pet Nutrition, Inc. Pet food compositions
WO2020121146A1 (en) 2018-12-13 2020-06-18 Societe Des Produits Nestle Sa Methods for increasing fat oxidation or energy expenditure or satiety in an animal
EP3893661A1 (en) 2018-12-13 2021-10-20 Société des Produits Nestlé S.A. Methods for enhancing metabolic health in an animal
CN111172055B (zh) * 2019-03-14 2022-06-10 南京农业大学 副干酪乳杆菌lhz-1及其在去除脱氧雪腐镰刀菌烯醇中的应用
WO2020243705A1 (en) * 2019-05-30 2020-12-03 New York University Probiotic compositions and methods of use
US20220233612A1 (en) * 2019-05-31 2022-07-28 South Dakota Board Of Regents Technology Transfer Office Probiotics to inhibit enteric pathogens
WO2021048362A1 (en) * 2019-09-13 2021-03-18 Aquilon Cyl S.L. Fermented milk product for administration in canids such as dogs, and uses thereof
CL2019003739A1 (es) * 2019-12-18 2020-06-19 Univ Concepcion Cepas probióticas de lactobacillus sp. y de pediococcus sp. y su uso en la elaboración de una formulación probiótica para prevención de diarreas causadas por patógenos bacterianos que afectan a perros y gatos.
AU2020410289A1 (en) 2019-12-19 2022-05-26 Societe Des Produits Nestle Sa Compositions and methods for providing a health benefit to a growing animal
JP7515153B2 (ja) * 2020-03-06 2024-07-12 学校法人麻布獣医学園 乳酸菌含有組成物
JP2023526979A (ja) 2020-05-29 2023-06-26 ソシエテ・デ・プロデュイ・ネスレ・エス・アー 動物における消化管の健康のための組成物及び方法
US12011468B2 (en) 2020-06-03 2024-06-18 Société des Produits Nestlé S.A. Compositions and methods for digestive health in an animal
BR112022026478A2 (pt) * 2020-06-29 2023-03-07 Canbiocin Inc Composições e métodos relacionados para suportar animais domésticos com distúrbios gastrointestinais
MX2023002625A (es) 2020-09-03 2023-03-17 Nestle Sa Composiciones y metodos para proporcionar beneficios para la salud en un animal.
AU2021337209A1 (en) 2020-09-04 2023-02-23 Societe Des Produits Nestle Sa Compositions and methods for providing health benefits in an animal
CN112266876A (zh) * 2020-11-02 2021-01-26 湖南海路生物科技有限公司 用于分离粪便中菌群的智能分离系统
KR102554078B1 (ko) * 2020-12-08 2023-07-10 건국대학교 산학협력단 애완동물을 위한 대사체 전환능 기반 유산균 조합 정보 제공 장치 및 방법
CA3199397A1 (en) 2020-12-11 2022-06-16 Manjuan Jenny She Compositions and methods for pet food
US20230165277A1 (en) 2021-11-29 2023-06-01 Société des Produits Nestlé S.A. Methods and compositions for providing a health benefit in an animal
US20230165281A1 (en) 2021-11-29 2023-06-01 Société des Produits Nestlé S.A. Methods and compositions for providing a health benefit in an animal
CN114437959B (zh) * 2021-11-29 2022-11-18 内蒙古普泽动保生物技术有限公司 一种动物双歧杆菌及其在抗氧化和提升免疫中的应用
CN118891052A (zh) * 2021-12-09 2024-11-01 雀巢产品有限公司 用以增加微生物群的胍丁胺产生的嗜酸乳杆菌
CN114292779A (zh) * 2021-12-22 2022-04-08 清远西周生物医药科技有限公司 一种副干酪乳杆菌冻干粉、其应用及制备方法
KR102766150B1 (ko) * 2021-12-23 2025-02-13 고민정 반려동물용 밀키트 사료의 제조방법 및 이에 따라 제조된 반려동물용 밀키트 사료
IT202200013138A1 (it) * 2022-06-22 2023-12-22 Cerbios Pharma Sa Probiotico per l’uso nel trattamento di alterazioni infiammatorie della mucosa intestinale, in particolare obesità
WO2024057113A1 (en) 2022-09-13 2024-03-21 Societe Des Produits Nestle Sa Methods for providing and determining an efficacious weight loss diet for a canine
AU2023343156A1 (en) 2022-09-14 2025-02-13 Societe Des Produits Nestle Sa Compositions and methods utilizing southern ocean mackerel oil for providing health benefits in an animal
KR102554206B1 (ko) * 2022-12-01 2023-07-13 (주)에이앤바이오 구강 항산화 증진을 통한 반려동물 치석 제거, 구취 개선, 잇몸 보호에 도움을 주는 카탈라아제 함유 반려동물 구강 건강 증진용 조성물
CN116333922A (zh) * 2023-02-10 2023-06-27 宁波希诺亚海洋生物科技有限公司 一株来源于深海大鱿鱼的鼠李糖乳杆菌菌株及其应用
KR102625196B1 (ko) * 2023-04-19 2024-01-15 박종호 기호도가 우수한 반려동물용 유산균 영양제 조성물
CN118497081B (zh) * 2024-07-09 2024-10-11 云南大学 一种发酵粘液乳杆菌iobra9848及其分离方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4160038A (en) * 1976-08-09 1979-07-03 Microlife Technics, Inc. Lactic acid fermentate flavored pet food
JPH07194317A (ja) * 1993-12-29 1995-08-01 Nichinichi Seiyaku Kk ペットフード
AUPM823094A0 (en) * 1994-09-16 1994-10-13 Goodman Fielder Limited Probiotic compositions
PT862863E (pt) * 1997-01-09 2002-04-29 Nestle Sa Produto cerealifero contendo probioticos
US5986569A (en) * 1997-03-20 1999-11-16 Micron Communications, Inc. Radio frequency identification system, radio frequency identification device package, and method of use of radio frequency identification device
WO1999017788A1 (en) * 1997-10-06 1999-04-15 Abbott Laboratories Composition of treatment of candidiasis
US5902743A (en) * 1998-03-20 1999-05-11 Wisconsin Alumni Research Foundation Probiotic bifidobacterium strain
JP4227690B2 (ja) * 1998-10-29 2009-02-18 株式会社バイオテックジャパン ペットフード
HUP0200374A2 (en) * 1999-03-11 2002-06-29 Nestle Sa Lactobacillus strains capable of preventing diarrhoea caused by pathogenic bacteria and rotaviruses
EP1034787A1 (en) * 1999-03-11 2000-09-13 Société des Produits Nestlé S.A. Lactobacillus strains preventing diarrhea caused by pathogenic bacteria
ES2262667T3 (es) * 2000-05-25 2006-12-01 Societe Des Produits Nestle S.A. Probioticos nuevos para aplicaciones en alimento para animales de compañia.

Also Published As

Publication number Publication date
EP1290136B1 (en) 2006-05-10
AU7843201A (en) 2001-12-03
MY138070A (en) 2009-04-30
WO2001090311A1 (en) 2001-11-29
US8124070B2 (en) 2012-02-28
JP4456649B2 (ja) 2010-04-28
NO20025528L (no) 2002-12-18
US7381406B2 (en) 2008-06-03
NZ523010A (en) 2004-06-25
ES2262667T3 (es) 2006-12-01
AU2001278432B2 (en) 2007-08-30
IL152695A (en) 2010-02-17
DE60127731D1 (de) 2007-05-16
US7189390B2 (en) 2007-03-13
PL359182A1 (en) 2004-08-23
HUP0301939A2 (hu) 2003-09-29
JP2009096811A (ja) 2009-05-07
DE60119515D1 (de) 2006-06-14
NO20025528D0 (no) 2002-11-18
US7771982B2 (en) 2010-08-10
CN100396769C (zh) 2008-06-25
US20080171106A1 (en) 2008-07-17
PL207930B1 (pl) 2011-02-28
AR029100A1 (es) 2003-06-04
EP1541673B1 (en) 2007-04-04
MXPA02011595A (es) 2003-03-27
KR100796963B1 (ko) 2008-01-22
CA2409286A1 (en) 2001-11-29
CN1444647A (zh) 2003-09-24
ZA200210302B (en) 2004-03-19
CA2409286C (en) 2012-05-15
JP2003534003A (ja) 2003-11-18
IL152695A0 (en) 2003-06-24
EP1290136A1 (en) 2003-03-12
US20100266549A1 (en) 2010-10-21
DE60127731T2 (de) 2007-08-16
EA006428B1 (ru) 2005-12-29
EA200201284A1 (ru) 2003-06-26
ATE325864T1 (de) 2006-06-15
US8771675B2 (en) 2014-07-08
UY26734A1 (es) 2001-11-30
NO330276B1 (no) 2011-03-21
EP1541673A1 (en) 2005-06-15
US20050106133A1 (en) 2005-05-19
DE60119515T2 (de) 2007-05-24
BR0111275A (pt) 2003-06-10
ES2284089T3 (es) 2007-11-01
US20070178079A1 (en) 2007-08-02
BR0111275B1 (pt) 2013-06-18
HU230800B1 (hu) 2018-06-28
JP4343477B2 (ja) 2009-10-14
HUP0301939A3 (en) 2004-04-28
KR20030010633A (ko) 2003-02-05
US20030190309A1 (en) 2003-10-09

Similar Documents

Publication Publication Date Title
PE20020232A1 (es) Bacterias acido lacticas como lactobacillus, bifidobacterium y streptococcus aisladas por su potencial probiotico para aplicaciones de alimento de mascotas
Cebeci et al. Properties of potential probiotic Lactobacillus plantarum strains
Presti et al. Evaluation of the probiotic properties of new Lactobacillus and Bifidobacterium strains and their in vitro effect
Ranadheera et al. Effect of dairy probiotic combinations on in vitro gastrointestinal tolerance, intestinal epithelial cell adhesion and cytokine secretion
Havenaar et al. Probiotics: a general view
Bernardeau et al. Safety and efficacy of probiotic lactobacilli in promoting growth in post-weaning Swiss mice
Iyer et al. Probiotic properties of folate producing Streptococcus thermophilus strains
Ljungh et al. Isolation, selection and characteristics of Lactobacillus paracasei subsp. paracasei F19
Melia et al. Selection of buffalo milk lactic acid bacteria with probiotic potential
Kaboosi Antibacterial effects of probiotics isolated from yoghurts against some common bacterial pathogens
DK0577904T3 (da) Mælkesyrebakterie.
Grześkowiak et al. Pathogen exclusion properties of canine probiotics are influenced by the growth media and physical treatments simulating industrial processes
Sharma et al. Probiotic efficacy and potential of Streptococcus thermophiles modulating human health: A synoptic review
Chiquette The role of probiotics in promoting dairy production.
CN105193860A (zh) 人工培养阴道菌群移植在妇科炎症中的应用方法
Millette et al. Characterization of probiotic properties of Lactobacillus strains
Suomalainen et al. In vitro and in vivo gastrointestinal survival, antibiotic susceptibility and genetic identification of Propionibacterium freudenreichii ssp. shermanii JS
RU2013126602A (ru) Нереплицирующиеся пробиотические микроорганизмы, защищающие детей против желудочно-кишечных инфекций
Lengkey et al. Effects of milk fermented with Lactobacillus acidophilus and Bifidobacterium spp., on lactic acid and acetic acid content and on Staphylococcus aureus and Pseudomonas aeruginosa.
Dastoor et al. Probiotics for life–Part I general health perspectives
Lee et al. Potential probiotic properties of Laetoeoeeus laetis NK34 isolated from Jeotgal
Mirnejad et al. Reduction of enterotoxigenic Escherichia coli colonization by the oral administration of Lactobacillus casei as a probiotic in a murine model
Salam Probiotics: Concept and applications
Mishra et al. Isolation and characterization of probiotic microorganism from fermented dairy products
Pirarat et al. In Vitro efficacy of human-derived probiotic, Lactobacillus rhamnosus against pathogenic bacteria in fish and frogs

Legal Events

Date Code Title Description
FC Refusal